Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans

Psychopharmacology

Volumn 232, Issue 2, 2015, Pages 343-353

  Theunissen, E L ^a   Heckman, P ^a   De Sousa Fernandes Perna, E B ^a   Kuypers, K P C ^a   Sambeth, A ^a   Blokland, A ^a   Prickaerts, J ^a   Toennes, S W ^b   Ramaekers, J G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Acetylcholine; Cannabis; Glutamate; Memory

Indexed keywords

ACETYLCHOLINE; CANNABIS; GLUTAMIC ACID; PLACEBO; RIVASTIGMINE; VARDENAFIL; CANNABINOID; CARBAMIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; PIPERAZINE DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; ATTENTION; CANNABIS USE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL TRACKING TASK; CROSSOVER PROCEDURE; DIVIDED ATTENTION TASK; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; IMPULSIVENESS; LEARNING AND MEMORY TEST; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOTOR CONTROL; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE MEMORY TASK; RECALL; STERNBERG MEMORY TASK; STOP SIGNAL TASK; TASK PERFORMANCE; VERBAL MEMORY; VISUAL VERBAL LEARNING TASK; ADVERSE EFFECTS; BLOOD; CANNABIS SMOKING; CLINICAL TRIAL; COGNITION; DRUG EFFECTS; LEARNING; MEMORY; MEMORY DISORDERS; METABOLISM; PROSPECTIVE STUDY; PSYCHOLOGY; SHORT TERM MEMORY; YOUNG ADULT;

ACETYLCHOLINE; ADULT; ATTENTION; CANNABINOIDS; CANNABIS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GLUTAMIC ACID; HUMANS; IMIDAZOLES; MALE; MARIJUANA SMOKING; MEMORY; MEMORY DISORDERS; MEMORY, SHORT-TERM; PHENYLCARBAMATES; PIPERAZINES; PROSPECTIVE STUDIES; SULFONES; TRIAZINES; VERBAL LEARNING; YOUNG ADULT;

EID: 84926490435     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3667-2     Document Type: Article

References (52)

1. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348
2. Atri A, Sherman S, Norman K.A., Kirchhoff BA, Nicolas MM, Greicius MD, Cramer S.C., Breiter HC, Hasselmo ME, Stern C.E. (2004) Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory task. Behav Neurosci 118:223
3. Bender AT, Beavo J.A. (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520
4. Bhattacharyya S, Fusar-Poli P, Borgwardt S., Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal M.L., Fletcher PC, Crippa J.A. (2009) Modulation of mediotemporal and ventrostriatal function in humans by A9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 66:442-451
5. Bischoff E (2004) Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events. Int J Impot Res 16: S34-S37
6. Bliss TVP, Collingridge G.L. (1993) A synaptic model of memory: longterm potentiation in the hippocampus. Nature 361:31-39
7. Bossong MG, Jansma JM, van Hell HH, Jager G, Oudman E, Saliasi E., Kahn RS, Ramsey N.F. (2012) Effects of 69-tetrahydrocannabinol on human working memory function. Biol Psychiatry 71:693-699
8. Braida D, Sala M. (2000) Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. Neuroreport 11:2025-2029
9. Chait LD, Perry J.L. (1994) Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology (Berl) 115:340-349
10. Curran HV, Brignell C, Fletcher S., Middleton P, Henry J. (2002) Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 164:61-70
11. Davies S, Pertwee R, Riedel G. (2002) Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42:993-1007
12. Dawson GR, Iversen S.D. (1993) The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav Brain Res 57:143-153
13. Devan BD, Pistell PJ, Daffin LW Jr, Nelson CM, Duffy KB, Bowker JL, Bharati I.S., Sierra-Mercado D, Spangler EL, Ingram D.K. (2007) Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor N ω-nitro-L-arginine methyl ester. Eur J Pharmacol 563:134-140
14. Ebmeier K, Hunter R, Curran S., Dougal N, Murray C, Wyper D., Patterson J, Hanson M, Siegfried K., Goodwin G. (1992) Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease. Psychopharmacology (Berl) 108:103-109
15. Egerton A, Allison C, Brett R.R., Pratt J.A. (2006) Cannabinoids and prefrontal cortical function: insights from preclinical studies. Neurosci Biobehav Rev 30:680-695
16. Fillmore MT, Rush CR, Hays L. (2002) Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67: 157-167
17. Giacobini E (2004) Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 50:433-440
18. Gottwald MD, Rozanski R.I. (1999) Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status. Expert Opin Investig Drugs 8:1673-1682
19. Hall W, Solowij N. (1998) Adverse effects of cannabis. Lancet 352:1611-1616
20. Hasselmo ME (2006) The role of acetylcholine in learning and memory. Curr Opin Neurobiol 16:710-715
21. Jex HR, McDonnell JD, Phatak A.V. (1966) A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR: 1-105.
22. Kathmann M, Weber B, Schlicker E. (2001) Cannabinoid CB 1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6 J mice. Naunyn Schmiedeberg's Arch Pharmacol 363:50-56
23. Klaassen T, Riedel W, Deutz N., Van Praag H (2002) Mood congruent memory bias induced by tryptophan depletion. Psychol Med 32: 167-172
24. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology (Berl) 126:125-131
25. Lichtman A, Varvel S, Martin B. (2002) Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fat Acids 66:269-285
26. Lindamood C, Colasanti B.K. (1980) Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus. J Pharmacol Exp Ther 213:216-221
27. Linssen A, Sambeth A, Vuurman E., Riedel W. (2014) Cognitive effects of methylphenidate and levodopa in healthy volunteers. Eur Neuropsychopharmacol 24:200-206
28. Logan GD (1994) On the ability to inhibit thought and action. In: Dagenbach D, Carr TH (eds) Inhibitory processes in attention, memory and language. Academic Press, San Diego, pp 189-239
29. Miller LL, Branconnier R.J. (1983) Cannabis: Effects on memory and the cholinergic limbic system. Psychol Bull 93:441
30. Moskowitz H (1973) Laboratory studies of the effects of alcohol on some variables related to driving. J Saf Res 5:185-192
31. Murray RM, Morrison PD, Henquet C, Di Forti M (2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8:885-895
32. 9-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration. Br J Pharmacol 130:1201-1210
33. Neitz A, Mergia E, Eysel U.T., Koesling D., Mittmann T. (2011) Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus. Eur J Neurosci 33:1611-1621
34. Pepeu G, Giovannini M.G. (2010) Cholinesterase inhibitors and memory. Chem Biol Interact 187:403-408
35. Prickaerts J, Van Staveren W, Şik A, Markerink-van Ittersum M, Niewöhner U, Van der Staay F, Blokland A, De Vente J (2002) Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 113:351-361
36. Ramaekers JG, Kuypers KPC (2006) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 31:1048-1055
37. Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller M.R. (2006) High-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control. Neuropsychopharmacology 31:2296-2303
38. Ramaekers JG, Kauert G, Theunissen E.L., Toennes SW, Moeller M.R. (2009a) Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol 23:266-277
39. Ramaekers JG, Kuypers KP, Wingen M, Heinecke A., Formisano E. (2009b) Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (ecstasy) intoxication: an event-related fMRI study. Neuropsychopharmacology 34:1641-1648
40. Ranganathan M, D'Souza DC (2006) The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) 188: 425-444
41. Reneerkens OA, Rutten K, Akkerman S., Blokland A, Shaffer CL, Menniti F.S., Steinbusch HW, Prickaerts J. (2012) Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms. Neurobiol Learn Mem 97:370-379
42. Reneerkens O, Sambeth A, Ramaekers J., Steinbusch H, Blokland A, Prickaerts J. (2013a) The effects of the phosphodiesterase type 5 inhibitor vardenafil on cognitive performance in healthy adults: a behavioral-electroencephalography study. J Psychopharmacol 27:600-608
43. Reneerkens O, Sambeth A, Van Duinen M, Blokland A, Steinbusch H., Prickaerts J. (2013b) The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans. Psychopharmacology (Berl) 225:303-312
44. Rey A (1964) L'examen Clinique en Psychologie. Presses Universitaires de France, Paris
45. Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H., Ebrahimi F, Dehpour A.R. (2006) The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br J Pharmacol 147:935-943
46. Riedel G, Platt B, Micheau J. (2003) Glutamate receptor function in learning and memory. Behav Brain Res 140:1-47
47. Schultheiss D, Müller S, Nager W., Stief C, Schlote N, Jonas U., Asvestis C, Johannes S, Münte T (2001) Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World J Urol 19:46-50
48. Shim Y, Pae C, Kim S., Kim H, Kim J, Koh J. (2011) Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study. Int J Impot Res 23:109-114
49. Sternberg S (1966) High-speed scanning in human memory. Science 153: 652-654
50. Toennes SW, Ramaekers JG, Theunissen E.L., Moeller MR, Kauert G.F. (2008) Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol 32:470-477
51. Uthayathas S, Karuppagounder SS, Thrash B.M., Parameshwaran K., Suppiramaniam V, Dhanasekaran M. (2007) Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep 59: 150-163
52. Uthayathas S, Parameshwaran K, Karuppagounder S.S., Ahuja M., Dhanasekaran M, Suppiramaniam V. (2013) Selective inhibition of phosphodiesterase 5 enhances glutamatergic synaptic plasticity and memory in mice. Synapse 67:741-747